Literature DB >> 30171220

Examining Balloon Expulsion Testing as an Office-Based, Screening Test for Dyssynergic Defecation: A Systematic Review and Meta-Analysis.

Eric D Shah1,1, Jeremy D Farida1, Stacy Menees1, Jason R Baker1, William D Chey1.   

Abstract

OBJECTIVES: Balloon expulsion testing (BET) is recommended to evaluate for dyssynergic defecation in patients with chronic constipation (CC). However, it remains poorly standardized and is limited to specialized centers. Our goal was to assess the clinical utility of balloon expulsion as an initial test for dyssynergic defecation and to determine appropriate testing parameters.
METHODS: We performed a literature search to identify cohort studies of unselected subjects with CC and case-control studies of subjects with/without dyssynergic defecation. We defined dyssynergic defecation by constipation symptoms and a positive reference test (anorectal manometry [ARM], defecography, or electromyography [EMG]). We performed a meta-analysis using a bivariate mixed-effects regression model to assess summary sensitivity, specificity, and area under the curve (AUC) with 95% confidence intervals (CI). We conducted a meta-regression to investigate individual test parameters and demographic variables.
RESULTS: We identified 15 eligible studies comprising 2090 individual assessments of BET. Among cohort studies, the AUC was 0.80 (95% CI: 0.61-0.91) with 70% sensitivity (95% CI: 52-83%) and 77% specificity (95% CI: 70-82%). In pooling cohort and case-control studies, the AUC was 0.84 (95% CI: 0.68-0.93) with 70% sensitivity (95% CI: 53-82%) and 81% specificity (95% CI: 75-86%). Subject positioning (seated vs. left lateral decubitus) did not significantly affect test performance in cohort (p = 0.82) or case-control (p = 0.43) analysis. Most studies evaluated 50-60 mL water insufflation. Test performance was not significantly affected by varying the maximum allowed expulsion time between 1 to 5 min. Age and gender likely accounted for significant study heterogeneity between studies. Choice of reference test, continent of study, and year of study did not significantly affect test performance. DISCUSSION: We report an optimized BET protocol. The performance characteristics of BET could support its use as a point of service test to screen for dyssynergic defecation in chronically constipated subjects.

Entities:  

Mesh:

Year:  2018        PMID: 30171220     DOI: 10.1038/s41395-018-0230-5

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

Review 1.  Review of the indications, methods, and clinical utility of anorectal manometry and the rectal balloon expulsion test.

Authors:  Adil E Bharucha; Guido Basilisco; Allison Malcolm; Tae Hee Lee; Matthew B Hoy; S Mark Scott; Satish S C Rao
Journal:  Neurogastroenterol Motil       Date:  2022-02-27       Impact factor: 3.960

2.  Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial.

Authors:  William D Chey; Jason R Baker; Lydia Watts; Adrienne Harris; Eric D Shah
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-02       Impact factor: 13.576

3.  Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System.

Authors:  Eric D Shah; Darren M Brenner; Vincent L Chen
Journal:  Dig Dis Sci       Date:  2021-03-29       Impact factor: 3.199

4.  Digital Rectal Examination Is a Valuable Bedside Tool for Detecting Dyssynergic Defecation: A Diagnostic Study and a Meta-Analysis.

Authors:  Jie Liu; Chaolan Lv; Yizhou Huang; Ying Wang; Dandan Wu; Cong Zhang; Chenyu Sun; Wei Wang; Yue Yu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-10-28

5.  Prevalence and Clinical Characteristics of Dyssynergic Defecation and Slow Transit Constipation in Patients with Chronic Constipation.

Authors:  Samuel Tanner; Ahson Chaudhry; Navneet Goraya; Rohan Badlani; Asad Jehangir; Dariush Shahsavari; Zubair Malik; Henry P Parkman
Journal:  J Clin Med       Date:  2021-05-09       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.